Considering the expression, prognosis, clinical value, and biological characteristics of the eight genes in both diseases, we ultimately determined EVPL and ENTPD3 to be the optimal shared genes in the biological context of T2DM and CRC. This evidence concerns the gene ENTPD3 and colorectal carcinoma.